Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi Core DAX UCITS ETF Dist
C001 · LU2611732046 · class UCITS ETF Dist · EUR · domicile Luxembourg
Equity · GermanySFDR art. 6
Index tracked: DAX INDEX
- TER
- 0.08%+ trans. 0.01%
- Fund size
- 1.5 bn EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingannual
Launch 7 Dec 2023 · costs from the KID as of 2 Sept 2026 · 42 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Sub-Fund is an index-tracking UCITS passively managed. The objective of this Sub-Fund is to track the performance of the DAX INDEX (the “Index”), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index: dividends net of tax paid by the Index constituents are included in the Index return. The Index is an equity index representative of…
Performance since series start (in euro) — base 100
29 Nov 2023 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +9.7% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +58.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 15.80% | 15.80% | — |
| Max drawdown | −12.33% | −12.33% | — |
| Sharpe | 0.34 | 0.34 | — |
| Sortino | 0.49 | 0.49 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · C001 · LU26117320461
RebalixC001 · LU2611732046 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +22.49% | +23.01% | −0.52% |
Distributions · per share, in EUR
Frequency: annual · last 12 months: 3.70 EUR (1.91% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 3.70 | +2.43% |
| 2024 | 1 | 3.31 | +2.51% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 42 securities · top-10 weight = 64.6%
| Top holdings | Weight |
|---|---|
| 11.5% | |
| 10.5% | |
| 9.7% | |
| 6.5% | |
| 6.5% | |
| 5.5% | |
| 4.1% | |
| 3.8% | |
| 3.7% | |
| 3.0% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
— · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
C001 · Xetra (Deutsche Börse)
+ 18 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2611732046
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2611732046
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · C001 · LU26117320462